• Home >
  • Publications >
  • Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes

Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes

1 Apr 2020JAMA Oncology

DOI : 10.1001/jamaoncol.2020.0056

Authors

Lisa Golmard, Jean-Louis Golmard, Dominique Stoppa-Lyonnet